Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam J Mead

Showing results (71-80 of 123) with videos related to

Pageof 13
Sort By:
Therapeutic Advances in Hematology|April 4, 2022
A retrospective real-world study of the current treatment pathways for myelofibrosis in the United Kingdom: the REALISM UK studyAdam J Mead, Nauman M Butt, Waseem Nagi, et al.
Cell Reports|June 4, 2013
FLT3-ITDs instruct a myeloid differentiation and transformation bias in lymphomyeloid multipotent progenitorsAdam J Mead, Shabnam Kharazi, Deborah Atkinson, et al.
Blood Advances|May 31, 2024
Safety and efficacy of luspatercept for the treatment of anemia in patients with myelofibrosisAaron T Gerds, Claire Harrison, Jean-Jacques Kiladjian, et al.
The Journal of Experimental Medicine|November 6, 2020
The mRNA m6A reader YTHDF2 suppresses proinflammatory pathways and sustains hematopoietic stem cell functionChristopher Mapperley, Louie N van de Lagemaat, Hannah Lawson, et al.
Nature Communications|November 26, 2021
A human fetal liver-derived infant MLL-AF4 acute lymphoblastic leukemia model reveals a distinct fetal gene expression programSiobhan Rice, Thomas Jackson, Nicholas T Crump, et al.
Nature Communications|October 6, 2019
Transcriptomic profiling of the myeloma bone-lining niche reveals BMP signalling inhibition to improve bone diseaseSarah Gooding, Sam W Z Olechnowicz, Emma V Morris, et al.
EMBO Molecular Medicine|July 10, 2025
SFX-01 is therapeutic against myeloproliferative disorders caused by activating mutations in Shp2Hyun-Ju Cho, Joy Smith, Christopher H Switzer, et al.
Blood|October 28, 2017
Ruxolitinib vs best available therapy for ET intolerant or resistant to hydroxycarbamideClaire N Harrison, Adam J Mead, Anesh Panchal, et al.
Blood Advances|June 6, 2020
Enhanced engraftment of human myelofibrosis stem and progenitor cells in MISTRG miceVeronika Lysenko, Nicole Wildner-Verhey van Wijk, Kathrin Zimmermann, et al.
Nature Medicine|May 16, 2017
Single-cell transcriptomics uncovers distinct molecular signatures of stem cells in chronic myeloid leukemiaAlice Giustacchini, Supat Thongjuea, Nikolaos Barkas, et al.
Pageof 13

Showing results (71-80 of 123) with videos related to

Sort By:
Pageof 13
Therapeutic Advances in Hematology|April 4, 2022
A retrospective real-world study of the current treatment pathways for myelofibrosis in the United Kingdom: the REALISM UK studyAdam J Mead, Nauman M Butt, Waseem Nagi, et al.
Cell Reports|June 4, 2013
FLT3-ITDs instruct a myeloid differentiation and transformation bias in lymphomyeloid multipotent progenitorsAdam J Mead, Shabnam Kharazi, Deborah Atkinson, et al.
Blood Advances|May 31, 2024
Safety and efficacy of luspatercept for the treatment of anemia in patients with myelofibrosisAaron T Gerds, Claire Harrison, Jean-Jacques Kiladjian, et al.
The Journal of Experimental Medicine|November 6, 2020
The mRNA m6A reader YTHDF2 suppresses proinflammatory pathways and sustains hematopoietic stem cell functionChristopher Mapperley, Louie N van de Lagemaat, Hannah Lawson, et al.
Nature Communications|November 26, 2021
A human fetal liver-derived infant MLL-AF4 acute lymphoblastic leukemia model reveals a distinct fetal gene expression programSiobhan Rice, Thomas Jackson, Nicholas T Crump, et al.
Nature Communications|October 6, 2019
Transcriptomic profiling of the myeloma bone-lining niche reveals BMP signalling inhibition to improve bone diseaseSarah Gooding, Sam W Z Olechnowicz, Emma V Morris, et al.
EMBO Molecular Medicine|July 10, 2025
SFX-01 is therapeutic against myeloproliferative disorders caused by activating mutations in Shp2Hyun-Ju Cho, Joy Smith, Christopher H Switzer, et al.
Blood|October 28, 2017
Ruxolitinib vs best available therapy for ET intolerant or resistant to hydroxycarbamideClaire N Harrison, Adam J Mead, Anesh Panchal, et al.
Blood Advances|June 6, 2020
Enhanced engraftment of human myelofibrosis stem and progenitor cells in MISTRG miceVeronika Lysenko, Nicole Wildner-Verhey van Wijk, Kathrin Zimmermann, et al.
Nature Medicine|May 16, 2017
Single-cell transcriptomics uncovers distinct molecular signatures of stem cells in chronic myeloid leukemiaAlice Giustacchini, Supat Thongjuea, Nikolaos Barkas, et al.
Pageof 13